Expert Consensus on Adverse Event Management for HR+ Metastatic Breast Cancer Treated with PI3K, AKT, and mTOR Inhibitors
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://www.MedLive.com
- Start Date: 2024-10-30 05:00:00
- End Date: 2024-10-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - Commercial Support: Source: AstraZeneca (Any division) - Amount: 249000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest